Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
04:30pm, Monday, 06'th Jan 2025
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 06'th Jan 2025
DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Monday, 06'th Jan 2025
WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet
02:01pm, Monday, 06'th Jan 2025
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.
Why T-Mobile Shares Plunged on a Strong Day for the Nasdaq
01:13pm, Monday, 06'th Jan 2025
Shares of T-Mobile (TMUS -3.99%) fell 4.3% on Monday as of 11:37 a.m. ET, a notable decline even as the Nasdaq Composite (^IXIC 1.53%) was up over 1.8% by that time.
The Real Good Food Company Announces Nasdaq Delisting
12:00pm, Monday, 06'th Jan 2025
CHERRY HILL, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) (“Real Good Foods” or the “Company ”), a leading health and wellness frozen and refrigerated
Nasdaq 100: Nvidia and Micron Surge as Chip Stocks Drive Market Rebound
09:39am, Monday, 06'th Jan 2025
Chip stocks surge as Nvidia, Micron, and AMD lift markets. Tariff relief boosts automakers.
Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally
09:17am, Monday, 06'th Jan 2025
A blog post from Sam Altman, the cofounder and CEO of OpenAI, may be helping drive AI stocks higher today.
NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
09:00am, Monday, 06'th Jan 2025
NeuroSense in Compliance with all Nasdaq Listing Requirements CAMBRIDGE, Mass. , Jan. 6, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
Moomoo Launches US Options Paper Trading Challenge, Co-branded with Nasdaq for Joint Promotion
08:30am, Monday, 06'th Jan 2025
Win Prizes and Potentially Elevate Your Options Trading Expertise with Moomoo's Pro-Level Trading Platform Risk-Free JERSEY CITY, N.J. , Jan. 6, 2025 /PRNewswire/ -- Moomoo, the intuitive investment a
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
08:30am, Monday, 06'th Jan 2025
CAESAREA, Israel , Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destr
SIMPPLE Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
08:30am, Monday, 06'th Jan 2025
Singapore, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd (Nasdaq: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management sector, today ann
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07:30am, Monday, 06'th Jan 2025
CAMBRIDGE, Mass, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therap
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Monday, 06'th Jan 2025
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted 1
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
06:00am, Monday, 06'th Jan 2025
SAN DIEGO--(BUSINESS WIRE)---- $REVB #GEMINI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing
